Compare Mutual Funds
Pros | - | Larger AUM within category. Beats FD returns for both 3Y & 5Y duration. | ||
Cons | - | 5Y returns in the bottom 25% of the category. 3Y returns in the bottom 25% of the category. |
INDMoney rank | - | 8/8 | ||
Category | Equity, Sector - Healthcare | Equity, Sector - Healthcare | ||
Fund Age | 4 Years 10 Months | 13 Years 10 Months | ||
Fund AUM | ₹263 Cr | ₹9279 Cr | ||
Min Investment |
|
| ||
Expense Ratio | 0.98% | 1% | ||
Exit Load | 0.5% | 1% | ||
Benchmark Index | Nifty Healthcare TR INR | BSE Healthcare TR INR |
No of Holdings | 39 | 38 | ||
Top 5 Holdings |
|
| ||
No of Sectors | 4 | 1 | ||
Top 3 Sectors |
| Health (100%) | ||
Equity % | 97.88% | 97.32% | ||
Debt % | - | - | ||
P/E | 43.65 | 39.56 | ||
P/B | 6.03 | 5.84 | ||
Credit Quality | - | - | ||
Modified Duration | - | - | ||
YTM | - | - |
1-Month Return | 0.31% | -0.13% | ||
3-Month Return | 10.23% | 7.73% | ||
6-Month Return | 17.83% | 13.29% | ||
1-Year Return | 13.12% | 11.67% | ||
3-Year Return | 20.53% | 19.37% | ||
5-Year Return | - | 13.55% |
Sharpe | 0.88 | 0.89 | ||
Alpha | 0.06 | -1.21 | ||
Beta | 0.95 | 0.88 | ||
Standard Deviation | 16.42 | 14.77 | ||
Information Ratio | -0.16 | -0.88 |
Description | ITI Pharma and Healthcare Fund is an equity fund.The fund could potentially beat inflation in the long-run. | Nippon India Pharma Fund is an equity fund.The fund could potentially beat inflation in the long-run. | ||
Managers | Animesh Singh, Nilay Dalal | Sailesh Raj Bhan, Kinjal Desai, Amber Singhania |

